P34: SAFETY AND IMMUNOLOGICAL RESPONSE TO 300IR HOUSE DUST MITE SUBLINGUAL TABLETS IN FOUR PHASE III TRIALS

Internal Medicine Journal ◽

10.1111/imj.34_14077 ◽

2018 ◽

Vol 48 ◽

pp. 14-14

Keyword(s):

House Dust Mite ◽

Immunological Response ◽

Phase Iii ◽

Dust Mite ◽

Phase Iii Trials

Download Full-text

Immunological Markers In House Dust Mite Allergic Subjects Treated With 300IR House Dust Mite Sublingual Tablets: Results From Two Phase III Trials

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.644 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB204

Author(s):

Pascal M. Demoly ◽

Karl-Christian Bergmann ◽

Yoshitaka Okamoto ◽

Kathy Abiteboul ◽

Kanchan Relwani

Keyword(s):

House Dust Mite ◽

Phase Iii ◽

Two Phase ◽

Immunological Markers ◽

Dust Mite ◽

Phase Iii Trials

Download Full-text

P105 House dust mite sublingual tablets: efficacy and safety results from two phase III trials

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2017.08.129 ◽

2017 ◽

Vol 119 (5) ◽

pp. S35

Author(s):

K. Bergmann ◽

K. Relwani ◽

Y. Okamoto

Keyword(s):

House Dust Mite ◽

Phase Iii ◽

Efficacy And Safety ◽

Two Phase ◽

Dust Mite ◽

Phase Iii Trials

Download Full-text

House dust mite-induced ATP release plays a role in the innate immunological response and barrier dysfunction of airway epithelium

Pneumologie ◽

10.1055/s-0032-1329799 ◽

2012 ◽

Vol 66 (11) ◽

Author(s):

S Post ◽

M Nawijn ◽

A van Oosterhout ◽

I Heijink

Keyword(s):

House Dust Mite ◽

Airway Epithelium ◽

Atp Release ◽

Immunological Response ◽

Barrier Dysfunction ◽

Download Full-text

Design of a pivotal phase III trial of allergen specific immunotherapy (AIT) using a high-dose house dust mite (HDM) allergoid in patients with allergic bronchial asthma

10.26226/morressier.5acc8ad4d462b8028d89b144 ◽

2018 ◽

Author(s):

Michael Rudert ◽

Viola Gödicke

Keyword(s):

Bronchial Asthma ◽

House Dust Mite ◽

Specific Immunotherapy ◽

Phase Iii ◽

High Dose ◽

Pivotal Phase ◽

Allergen Specific Immunotherapy ◽

Phase Iii Trial ◽

Download Full-text

Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet

Allergology International ◽

10.1016/j.alit.2019.07.007 ◽

2020 ◽

Vol 69 (1) ◽

pp. 104-110 ◽

Author(s):

Minoru Gotoh ◽

Kimihiro Okubo ◽

Atsushi Yuta ◽

Yukiko Ogawa ◽

Hitoshi Nagakura ◽

...

Keyword(s):

House Dust Mite ◽

Safety Profile ◽

Sublingual Immunotherapy ◽

Immunological Response ◽

Japanese Cedar ◽

Dust Mite ◽

Japanese Cedar Pollen ◽

Download Full-text

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2020.07.036 ◽

2020 ◽

Author(s):

Pascal Demoly ◽

Jonathan Corren ◽

Peter Creticos ◽

Frédéric De Blay ◽

Philippe Gevaert ◽

...

Keyword(s):

Clinical Trial ◽

Allergic Rhinitis ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Sublingual Tablet ◽

Double Blind Placebo ◽

Phase Iii Clinical Trial ◽

Download Full-text

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2015.06.036 ◽

2016 ◽

Vol 137 (2) ◽

pp. 444-451.e8 ◽

Author(s):

Pascal Demoly ◽

Waltraud Emminger ◽

Dorte Rehm ◽

Vibeke Backer ◽

Lene Tommerup ◽

...

Keyword(s):

Allergic Rhinitis ◽

Effective Treatment ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725732326.793549421 ◽

2018 ◽

Author(s):

Harold Nelson

Keyword(s):

Allergic Rhinitis ◽

Effective Treatment ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Download Full-text

ASCIA-P47: 300IR SUBLINGUAL TABLET OF HOUSE DUST MITE ALLERGEN EXTRACTS: EFFICACY ON RHINITIS SYMPTOMS IN SUBJECTS WITH HOUSE DUST MITE-ASSOCIATED ALLERGIC RHINITIS IN TWO PHASE III STUDIES

Internal Medicine Journal ◽

10.1111/imj.47_13197 ◽

2016 ◽

Vol 46 ◽

pp. 19-19

Author(s):

Yoshitaka Okamoto ◽

Alicia Parkes ◽

Shinji Kakudo ◽

Kathy Abiteboul

Keyword(s):

House Dust Mite ◽

Phase Iii ◽

Two Phase ◽

House Dust Mite Allergen ◽

Sublingual Tablet ◽

Dust Mite ◽

Dust Mite Allergen ◽

Allergen Extracts ◽

Phase Iii Studies

Download Full-text

The HDM Slit-Tablet Reduces Symptoms of House Dust Mite Allergic Rhinitis Independently of Asthma Status and Allergen Sensitisation Type; A Subgroup Analysis of Results from a Dbpc Phase III Trial (MERIT)

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2014.12.1816 ◽

2015 ◽

Vol 135 (2) ◽

pp. AB268

Author(s):

Joerg R. Kleine-Tebbe ◽

Kjersti Moen ◽

Dorte Rehm ◽

Pascal M. Demoly

Keyword(s):

Allergic Rhinitis ◽

House Dust Mite ◽

Subgroup Analysis ◽

Type A ◽

Phase Iii ◽

Phase Iii Trial ◽

Asthma Status ◽

Dust Mite ◽

Analysis Of Results

Download Full-text